Onconova Therapeutics Inc. (ONTX) |
|
0.3475 0.055 (18.97%)
|
12-06 10:41 |
|
Open: |
0.374 |
Pre. Close: |
0.2921 |
|
High:
|
0.38 |
Low:
|
0.336 |
|
Volume:
|
23,494,281 |
Market Cap:
|
13M |
|
|
|
|
Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule drug candidates to treat cancer. The Company has three clinical-stage product candidates and six preclinical programs. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.31 - 0.312 |
0.312 - 0.313 |
|
Low:
|
0.256 - 0.258 |
0.258 - 0.26 |
|
Close:
|
0.287 - 0.29 |
0.29 - 0.293 |
|
Technical analysis |
as of: 2019-12-06 10:31:23 AM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 0.69  One year: 0.80 |
| Support: |
Support1: 0.29 Support2: 0.10 |
| Resistance: |
Resistance1: 0.59 Resistance2: 0.69 |
| Pivot: |
0.26 |
| Moving Average: |
MA(5): 0.32 MA(20): 0.29 
MA(100): 1.41 MA(250): 2.53 |
| MACD: |
MACD(12,26): -0.10 Signal(9): -0.14 |
| Stochastic oscillator: |
%K(14,3): 45.71 %D(3): 44.72 |
| RSI: |
RSI(14): 46.92 |
| 52-week: |
High: 4.83 Low: 0.10 Change(%): -90.0 |
| Average Vol(K): |
3-Month: 646291 10-Days: 3225674 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ONTX has closed below upper band by 22.7%. Bollinger Bands are 48.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to ONTX's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2019-11-25
Onconova Therapeutics, Inc. Announces Closing of $11.0 Million Public Offering
Offering led by healthcare dedicated funds, including Knight Therapeutics Inc., along with officers and directors of Onconova
2019-11-22
The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) (raised full-year guidance following completion of Otezla purchase from Celgene) Antares Pharma Inc (NASDAQ: ATRS ) Arvinas Inc (NASDAQ: ARVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) BIO-TECHNE Corp (NASDAQ: TECH ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Cue Biopharma Inc (NASDAQ: CUE ) Epizyme Inc (NASDAQ: EPZM ) Kamada Ltd. (NASDAQ: KMDA ) Kodiak Sciences Inc (NASDAQ: KOD ) Molecular Templates Inc (NASDAQ: MTEM ) Recro Pharma Inc (NASDAQ: REPH ) (completed spin-off of Baudax Bio in a bid to a become a pure play CDMO) Down In The Dumps (Biotech stocks that hit 52-week lows on Nov. 21.) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) (received European approval for its Rhokiinsa 0.02% for the reduction of elevated intraocular pressure) Affimed NV (NASDAQ: AFMD ) Anixa Biosciences Inc (NASDAQ: ANIX ) CareDx Inc (NASDAQ: CDNA ) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) ENDRA Life Sciences Inc (NASDAQ: NDRA ) Genprex Inc (NASDAQ: GNPX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Interpace Biosciences Inc (NASDAQ: IDXG ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) (priced its previously announced common stock offering) Iterum Therapeutics PLC (NASDAQ: ITRM ) Jaguar Health Inc (NASDAQ: JAGX ) MacroGenics Inc (NASDAQ: MGNX ) Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) Neon Therapeutics Inc (NASDAQ: NTGN ) (announced a changed focus and the elimination of 24% of workforce) Novavax, Inc. (NASDAQ: NVAX ) Nuvectra Corp (NASDAQ: NVTR ) Onconova Therapeutics …
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
